Narcolepsy: the impact of aging, hypocretin deficiency, and years of formal education in olfactory function and abdominal obesity

ABSTRACT

Background: Narcolepsy is a disease resulting from the loss of hypocretin-producing cells or other dysfunctions of the hypocretinergic system. In addition to sleep disorders, affected patients may experience increased weight gain, olfactory changes, and poorer quality of life. Methods: This study aimed to investigate the relationship between narcolepsy and weight gain, years of study, sleep parameters, and olfactory dysfunction in patients with narcolepsy type 1 and narcolepsy type 2. Anthropometric, olfactory, socioeducational, and excessive daytime sleepiness evaluations were performed in 77 patients. Results: Greater weight gain and abdominal obesity were observed in patients with type 1 narcolepsy. Patients with higher education level had lower scores of daytime sleepiness, higher scores on the olfactory function test, and lower rates of abdominal obesity. Discussion: Patients with narcolepsy type 1 showed an increased body weight and abdominal obesity when compared to narcolepsy type 2. The patients with a higher schooling level showed a reduction of the daytime sleepiness scores, lower rates of abdominal obesity, and better scores on the olfactory function test. Conclusion: Among all the patients with narcolepsy, the data indicated that aging and hypocretin deficiency are associated with abdominal obesity, while years of study is the variable that mostly influences olfaction function.

RESUMO

Antecedentes: A narcolepsia é resultante da perda de células produtoras de hipocretina ou da disfunção do sistema hipocretinérgico. Além dos distúrbios do sono característicos da doença, os pacientes afetados podem apresentar também aumento de peso, alterações olfatórias e pior qualidade de vida. Métodos: O objetivo do estudo é investigar a relação entre a narcolepsia e o ganho de peso, anos de estudo, parâmetros do sono e a disfunção olfatória em pacientes com narcolepsia tipo 1 e narcolepsia tipo 2. Foram realizadas avaliações antropométricas, do olfato, sociais, educacionais e da sonolência excessiva diurna nos 77 indivíduos participantes da pesquisa. Resultados: Foram observados, nos pacientes com narcolepsia tipo 1, maior ganho de peso e maior frequência de obesidade central. Pacientes com ensino superior apresentaram escores mais baixos de sonolência excessiva diurna, escores mais altos no teste de função olfatória e menores taxas de obesidade central. Discussão: Pacientes com narcolepsia tipo 1 apresentaram maior ganho de peso e obesidade central quando comparados aos com narcolepsia tipo 2. Os pacientes com maior escolaridade apresentaram menores escores de sonolência diurna, de obesidade central e melhores escores no teste da função olfatória. Conclusão: Nos indivíduos com narcolepsia tipo 1 e tipo 2, os dados indicaram que o envelhecimento e a deficiência de hipocretina estão associados à obesidade central, enquanto anos de estudo é a variável que mais influencia na função olfatória.

Keywords:

Disorders of Excessive Somnolence - Hyposmia - Central Obesity - Education - Orexin

Palavras-chave:

Distúrbios do Sono por Sonolência Excessiva - Hiposmia - Obesidade Central - Educação - Orexina

• REFERENCES

• 1 Morrish E, King MA, Smith IE, Shneerson JM. Factors associated with a delay in the diagnosis of narcolepsy. Sleep Med. 2004 Jan;5(1):37-41. https://doi.org/10.1016/j.sleep.2003.06.002
• 2 American Academy of Sleep Medicine. International classification of sleep disorders. 3rd ed. Darien (IL): AASM; 2014.
• 3 Blouin AM, Thannickal TC, Worley PF, Baraban JM, Reti IM, Siegel JM. Narp immunostaining of human hypocretin (orexin) neurons: loss in narcolepsy. Neurology. 2005 Oct 25;65(8):1189-92. https://doi.org/10.1212/01.wnl.0000175219.01544.c8
• 4 Andlauer O, Moore Ht, Hong S-C, Dauvilliers Y, Kanbayashi T, Nishino S, et al. Predictors of hypocretin (orexin) deficiency in narcolepsy without cataplexy. Sleep. 2012 Sep 1;35(9):1247-55. https://doi.org/10.5665/sleep.2080
• 5 Peyron C, Faraco J, Rogers W, Ripley B, Overeem S, Charnay Y, et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med. 2000 Sep;6(9):991-7. https://doi.org/10.1038/79690
• 6 Guilleminault C, Mignot E, Grumet FC. Familial patterns of narcolepsy. Lancet. 1989 Dec 9;2(8676):1376-9. https://doi.org/10.1016/S0140-6736(89)91977-6
• 7 Rocca FL, Finotti E, Pizza F, Ingravallo F, Gatta M, Bruni O, et al. Psychosocial profile and quality of life in children with type 1 narcolepsy: a case-control study. Sleep. 2016 Jul 1;39(7):1389-98. https://doi.org/10.5665/sleep.5970
• 8 Baier PC, Weinhold SL, Huth V, Gottwald B, Ferstl R, Hinze-Selch D. Olfactory dysfunction in patients with narcolepsy with cataplexy is restored by intranasal Orexin A (Hypocretin-1). Brain. 2008 Oct;131(10):2734-41. https://doi.org/10.1093/brain/awn193
• 9 Bayard S, Plazzi G, Poli F, Serra L, Ferri R, Dauvilliers Y. Olfactory dysfunction in narcolepsy with cataplexy. SleepMed. 2010 Oct;11(9):876-81. https://doi.org/10.1016/j.sleep.2010.07.004
• 10 Buskova J, Klaschka J, Sonka K, Nevsimalova S. Olfactory dysfunction in narcolepsy with and without cataplexy. Sleep Med. 2010 Jun;11(6):558-61. https://doi.org/10.1016/j.sleep.2010.01.009
• 11 Gorojankina T, Grébert D, Salesse R, Tanfin Z, Caillol M. Study of orexins signal transduction pathways in rat olfactory mucosa and in olfactory sensory neurons-derived cell line Odora: multiple orexin signalling pathways. Regul Pept. 2007 Jun 7;141(1-3):73-85. https://doi.org/10.1016/j.regpep.2006.12.012
• 12 Nixon JP, Mavanji V, Butterick TA, Billington CJ, Kotz CM, Teske JA. Sleep disorders, obesity, and aging: the role of orexin. Ageing Res Rev. 2015 Mar;20:63-73. https://doi.org/10.1016/j.arr.2014.11.001
• 13 Bassetti CLA, Adamantidis A, Burdakov D, Han F, Gay S, Kallweit U, et al. Narcolepsy - clinical spectrum, aetiopathophysiology, diagnosis and treatment. Nat Rev Neurol. 2019 Sep;15(9):519-39. https://doi.org/10.1038/s41582-019-0226-9
• 14 Miyagawa T, Kawamura H, Obuchi M, Ikesaki A, Ozaki A, Tokunaga K, et al. Effects of oral L-carnitine administration in narcolepsy patients: a randomized, double-blind, cross-over and placebo-controlled trial. PLoS One. 2013;8(1):e53707. https://doi.org/10.1371/journal.pone.0053707
• 15 Bertolazi AN, Fagondes SC, Hoff LS, Pedro VD, Barreto SSM, Johns MW. Portuguese-language version of the Epworth sleepiness scale: validation for use in Brazil. J Bras Pneumol. 2009 Sep;35(9):877-83. https://doi.org/10.1590/S1806-37132009000900009
• 16 World Health Organization. Public Health Nutrition. Geneva: WHO; 2004.
• 17 World Health Organization. Waist circumference and waist-hip ratio: report of WHO expert consultation. Geneva: WHO; 2008.
• 18 Emdin CA, Khera AV, Natarajan P, Klarin D, Zekavat SM, Hsiao AJ, et al. Genetic association of waist-to-Hip Ratio with Cardiometabolic Traits, type 2 diabetes, and coronary heart disease. JAMA. 2017 Feb 14;317(6):626-34. https://doi.org/10.1001/jama.2016.21042
• 19 Fornazieri MA, Doty RL, Santos CA, Pinna F de R, Bezerra TFP, Voegels RL. A new cultural adaptation of the University of Pennsylvania Smell Identification Test. Clinics (São Paulo). 2013 Jan;68(1):65-8. https://doi.org/10.6061/clinics/2013(01)OA10
• 20 Sonka K, Kemlink D, Busková J, Pretl M, Srůtková Z, Horvat EM, et al. Obesity accompanies narcolepsy with cataplexy but not narcolepsy without cataplexy. Neuro Endocrinol Lett. 2010;31(5):631-4.
• 21 Drissi NM, Romu T, Landtblom A-M, Szakács A, Hallböök T, Darin N, et al. Unexpected fat distribution in adolescents with Narcolepsy. Front Endocrinol (Lausanne). 2018 Dec 6;9:728. https://doi.org/10.3389/fendo.2018.00728
• 22 Liu M-M, Liu Q-J, Wen J, Wang M, Wu L-Y, Qu M-L, et al. Waist-to-hip ratio is the most relevant obesity index at each phase of insulin secretion among obese patients. J Diabetes Complications. 2018 Jul;32(7):670-6. https://doi.org/10.1016/j.jdiacomp.2018.04.006
• 23 González DA, Nazmi A, Yudkin JS, Victora CG. Life-course socio-economic factors, skin colour and abdominal obesity in adulthood in a Brazilian birth cohort. Public Health Nutr. 2009 Nov;12(11):2225-35. https://doi.org/10.1017/S1368980009990607
• 24 Jennum P, Ibsen R, Knudsen S, Kjellberg J. Comorbidity and mortality of narcolepsy: a controlled retro- and prospective national study. Sleep. 2013 Jun 1;36(6):835-40. https://doi.org/10.5665/sleep.2706
• 25 Cohen A, Mandrekar J, St Louis EK, Silber MH, Kotagal S. Comorbidities in a community sample of narcolepsy. Sleep Med. 2018 Mar;43:14-8. https://doi.org/10.1016/j.sleep.2017.11.1125
• 26 Inocente CO, Lavault S, Lecendreux M, Dauvilliers Y, Reimao R, Gustin M-P, et al. Impact of obesity in children with narcolepsy. CNS Neurosci Ther. 2013 Jul;19(7):521-8. https://doi.org/10.1111/cns.12105
• 27 Wang Z, Wu H, Stone WS, Zhuang J, Qiu L, Xu X, et al. Body weight and basal metabolic rate in childhood narcolepsy: a longitudinal study. Sleep Med. 2016 Sep;25:139-44. https://doi.org/10.1016/j.sleep.2016.06.019
• 28 Fronczek R, Lammers GJ, Balesar R, Unmehopa UA, Swaab DF. The number of hypothalamic hypocretin (orexin) neurons is not affected in Prader-Willi syndrome. J Clin Endocrinol Metab. 2005 Sep;90(9):5466-70. https://doi.org/10.1210/jc.2005-0296
• 29 van Holst RJ, van der Cruijsen L, van Mierlo P, Lammers GJ, Cools R, Overeem S, et al. Aberrant food Choices after Satiation in Human Orexin-Deficient Narcolepsy Type 1. Sleep. 2016 Nov 1;39(11):1951-9. https://doi.org/10.5665/sleep.6222
• 30 Serretti A, Mandelli L. Antidepressants and body weight: a comprehensive review and meta-analysis. J Clin Psychiatry. 2010 Oct;71(10):1259-72. https://doi.org/10.4088/JCP.09r05346blu
• 31 Instituto Brasileiro de Geografia e Estatística [Internet]. Pesquisa nacional por amostra de domicílios. Brasília: IBGE; 2015. Available from: https://www.ibge.gov.br/estatisticas/sociais/educacao/9127-pesquisa-nacional-por-amostra-de-domicilios.html?=&t=resultados
• 32 Jennum P, Knudsen S, Kjellberg J. The economic consequences of narcolepsy. J Clin Sleep Med. 2009 Jun 15;5(3):240-5.
• 33 Bayard S, Croisier ML, Cochen De Cock V, Scholz S, Dauvilliers Y. Executive control of attention in narcolepsy. PloS One. 2012 Apr 25;7(4):e33525. https://doi.org/10.1371/journal.pone.0033525
• 34 Inocente CO, Lavault S, Lecendreux M, Dauvilliers Y, Reimao R, Gustin M-P, et al. Impact of obesity in children with Narcolepsy. CNS Neurosci Ther. 2013 Jul;19(7):521-8. https://doi.org/10.1111/cns.12105
• 35 Hagman E, Danielsson P, Brandt L, Svensson V, Ekbom A, Marcus C. Childhood obesity, obesity treatment outcome, and achieved education: a prospective cohort study. J Adolesc Health. 2017 Oct;61(4):508-13. https://doi.org/10.1016/j.jadohealth.2017.04.009
• 36 Fornazieri MA, Doty RL, Bezerra TFP, Pinna F de B, Costa FO, Voegels RL, et al. Relationship of socioeconomic status to olfactory function. Physiol Behav. 2019 Jan 1;198:84-9. https://doi.org/10.1016/j.physbeh.2018.10.011
• 37 Plazzi G, Moghadam KK, Maggi LS, Donadio V, Vetrugno R, Liguori R, et al. Autonomic disturbances in narcolepsy. Sleep Med Rev. 2011 Jun;15(3):187-96. https://doi.org/10.1016/j.smrv.2010.05.002
• 38 Klein G, Burghaus L, Vaillant M, Pieri V, Fink GR, Diederich N. Dysautonomia in narcolepsy: evidence by questionnaire assessment. J Clin Neurol. 2014 Oct 6;10(4):314-9. https://doi.org/10.3988/jcn.2014.10.4.314
• 39 Peyron C, Tighe DK, van den Pol AN, de Lecea L, Heller HC, Sutcliffe JG, et al. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci. 1998 Dec 1;18(23):9996-10015. https://doi.org/10.1523/JNEUROSCI.18-23-09996.1998
• 40 Huang Y-S, Hsiao I-T, Liu F-Y, Hwang F-M, Lin K-L, Huang W-C, et al. Neurocognition, sleep, and PET findings in type 2 vs type 1 narcolepsy. Neurology. 2018 Apr 24;90(17):e1478-87. https://doi.org/10.1212/WNL.20200352202003525346
• 41 Szakacs Z, Dauvilliers Y, Mikhaylov V, Poverennova I, Krylov S, Jankovic S, et al. Safety and efficacy of pitolisant on cataplexy in patients with narcolepsy: a randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2017 Mar;16(3):200-7. https://doi.org/10.1016/S1474-4422(16)30333-7
• 42 Smith S, Rossdale J, Serry Y, Sekaran A, Drakatos P, Steier J. Multiple dimensions of excessive daytime sleepiness. J Thorac Dis. 2018 Jan;10 Suppl 1:S170-6. https://doi.org/10.21037/jtd.2017.11.32
• 43 Fong SY, Ho CK, Wing YK. Comparing MSLT and ESS in the measurement of excessive daytime sleepiness in obstructive sleep apnoea syndrome. J Psychosom Res. 2005 Jan;58(1):55-60. https://doi.org/10.1016/j.jpsychores.2004.05.004
• 44 Vignatelli L, Plazzi G, Barbato A, Ferini-Strambi L, Manni R, Pompei F, et al. Italian version of the Epworth sleepiness scale: external validity. Neurol Sci. 2003 Feb;23(6):295-300. https://doi.org/10.1007/s100720300004
• 45 Marra L, Carratu P, Dragonieri S, Quaranta VN, Castellana G, Resta O. The role of education in the self-compilation of Epworth sleepiness scale questionnaire in patients with suspected obstructive sleep apnea. Sleep Breath. 2018 May;22(2):485-6. https://doi.org/10.1007/s11325-017-1586-2
• 46 Gander PH, Marshall NS, Harris R, Reid P. The Epworth Sleep iness scale: influence of age, ethnicity, and socioeconomic deprivation. Epworth Sleep iness scores of adults in New Zealand. Sleep. 2005 Feb;28(2):249-54. https://doi.org/10.1093/sleep/28.2.249